UiPath Inc.

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, MSFT has a market cap of 3.1T. Regarding current trading prices, PATH is priced at $10.66, while MSFT trades at $412.66.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas MSFT's P/E ratio is 24.61. In terms of profitability, PATH's ROE is +0.15%, compared to MSFT's ROE of +0.33%. Regarding short-term risk, PATH is more volatile compared to MSFT. This indicates potentially higher risk in terms of short-term price fluctuations for PATH.Check MSFT's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, ORCL has a market cap of 557.5B. Regarding current trading prices, PATH is priced at $10.66, while ORCL trades at $193.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas ORCL's P/E ratio is 34.86. In terms of profitability, PATH's ROE is +0.15%, compared to ORCL's ROE of +0.57%. Regarding short-term risk, PATH is more volatile compared to ORCL. This indicates potentially higher risk in terms of short-term price fluctuations for PATH.Check ORCL's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, PLTR has a market cap of 314.3B. Regarding current trading prices, PATH is priced at $10.66, while PLTR trades at $136.89.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas PLTR's P/E ratio is 152.10. In terms of profitability, PATH's ROE is +0.15%, compared to PLTR's ROE of +0.32%. Regarding short-term risk, PATH is less volatile compared to PLTR. This indicates potentially lower risk in terms of short-term price fluctuations for PATH.Check PLTR's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, PANW has a market cap of 145.7B. Regarding current trading prices, PATH is priced at $10.66, while PANW trades at $213.66.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas PANW's P/E ratio is 118.08. In terms of profitability, PATH's ROE is +0.15%, compared to PANW's ROE of +0.15%. Regarding short-term risk, PATH is less volatile compared to PANW. This indicates potentially lower risk in terms of short-term price fluctuations for PATH.Check PANW's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, CRWD has a market cap of 137.5B. Regarding current trading prices, PATH is priced at $10.66, while CRWD trades at $542.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas CRWD's P/E ratio is -860.73. In terms of profitability, PATH's ROE is +0.15%, compared to CRWD's ROE of -0.05%. Regarding short-term risk, PATH is less volatile compared to CRWD. This indicates potentially lower risk in terms of short-term price fluctuations for PATH.Check CRWD's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, ADBE has a market cap of 99.5B. Regarding current trading prices, PATH is priced at $10.66, while ADBE trades at $246.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas ADBE's P/E ratio is 14.34. In terms of profitability, PATH's ROE is +0.15%, compared to ADBE's ROE of +0.62%. Regarding short-term risk, PATH is less volatile compared to ADBE. This indicates potentially lower risk in terms of short-term price fluctuations for PATH.Check ADBE's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, SNPS has a market cap of 98.9B. Regarding current trading prices, PATH is priced at $10.66, while SNPS trades at $516.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas SNPS's P/E ratio is 79.29. In terms of profitability, PATH's ROE is +0.15%, compared to SNPS's ROE of +0.05%. Regarding short-term risk, PATH is more volatile compared to SNPS. This indicates potentially higher risk in terms of short-term price fluctuations for PATH.Check SNPS's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, FTNT has a market cap of 85.4B. Regarding current trading prices, PATH is priced at $10.66, while FTNT trades at $115.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas FTNT's P/E ratio is 44.74. In terms of profitability, PATH's ROE is +0.15%, compared to FTNT's ROE of +1.56%. Regarding short-term risk, PATH is more volatile compared to FTNT. This indicates potentially higher risk in terms of short-term price fluctuations for PATH.Check FTNT's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, NET has a market cap of 68.3B. Regarding current trading prices, PATH is priced at $10.66, while NET trades at $193.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas NET's P/E ratio is -773.64. In terms of profitability, PATH's ROE is +0.15%, compared to NET's ROE of -0.06%. Regarding short-term risk, PATH is less volatile compared to NET. This indicates potentially lower risk in terms of short-term price fluctuations for PATH.Check NET's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, VMW has a market cap of 61.5B. Regarding current trading prices, PATH is priced at $10.66, while VMW trades at $142.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas VMW's P/E ratio is 42.92. In terms of profitability, PATH's ROE is +0.15%, compared to VMW's ROE of +3.99%. Regarding short-term risk, PATH is more volatile compared to VMW. This indicates potentially higher risk in terms of short-term price fluctuations for PATH.Check VMW's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, CRWV has a market cap of 60.6B. Regarding current trading prices, PATH is priced at $10.66, while CRWV trades at $114.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas CRWV's P/E ratio is -42.17. In terms of profitability, PATH's ROE is +0.15%, compared to CRWV's ROE of -0.40%. Regarding short-term risk, PATH is less volatile compared to CRWV. This indicates potentially lower risk in terms of short-term price fluctuations for PATH.Check CRWV's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, SQ has a market cap of 51.7B. Regarding current trading prices, PATH is priced at $10.66, while SQ trades at $83.46.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas SQ's P/E ratio is 49.98. In terms of profitability, PATH's ROE is +0.15%, compared to SQ's ROE of -0.02%. Regarding short-term risk, PATH is more volatile compared to SQ. This indicates potentially higher risk in terms of short-term price fluctuations for PATH.Check SQ's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, XYZ has a market cap of 43.6B. Regarding current trading prices, PATH is priced at $10.66, while XYZ trades at $73.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas XYZ's P/E ratio is 57.17. In terms of profitability, PATH's ROE is +0.15%, compared to XYZ's ROE of +0.04%. Regarding short-term risk, PATH is less volatile compared to XYZ. This indicates potentially lower risk in terms of short-term price fluctuations for PATH.Check XYZ's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, NETE has a market cap of 27.8B. Regarding current trading prices, PATH is priced at $10.66, while NETE trades at $13.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas NETE's P/E ratio is N/A. In terms of profitability, PATH's ROE is +0.15%, compared to NETE's ROE of +3.34%. Regarding short-term risk, PATH is less volatile compared to NETE. This indicates potentially lower risk in terms of short-term price fluctuations for PATH.Check NETE's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, SPLK has a market cap of 26.4B. Regarding current trading prices, PATH is priced at $10.66, while SPLK trades at $156.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas SPLK's P/E ratio is 103.22. In terms of profitability, PATH's ROE is +0.15%, compared to SPLK's ROE of +0.84%. Regarding short-term risk, PATH is more volatile compared to SPLK. This indicates potentially higher risk in terms of short-term price fluctuations for PATH.Check SPLK's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, VRSN has a market cap of 26.1B. Regarding current trading prices, PATH is priced at $10.66, while VRSN trades at $286.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas VRSN's P/E ratio is 31.65. In terms of profitability, PATH's ROE is +0.15%, compared to VRSN's ROE of -0.40%. Regarding short-term risk, PATH is more volatile compared to VRSN. This indicates potentially higher risk in terms of short-term price fluctuations for PATH.Check VRSN's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, ZS has a market cap of 23.9B. Regarding current trading prices, PATH is priced at $10.66, while ZS trades at $148.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas ZS's P/E ratio is -346.21. In terms of profitability, PATH's ROE is +0.15%, compared to ZS's ROE of -0.03%. Regarding short-term risk, PATH is less volatile compared to ZS. This indicates potentially lower risk in terms of short-term price fluctuations for PATH.Check ZS's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, MDB has a market cap of 23.7B. Regarding current trading prices, PATH is priced at $10.66, while MDB trades at $294.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas MDB's P/E ratio is -338.68. In terms of profitability, PATH's ROE is +0.15%, compared to MDB's ROE of -0.02%. Regarding short-term risk, PATH is less volatile compared to MDB. This indicates potentially lower risk in terms of short-term price fluctuations for PATH.Check MDB's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, CPAY has a market cap of 22.6B. Regarding current trading prices, PATH is priced at $10.66, while CPAY trades at $341.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas CPAY's P/E ratio is 20.49. In terms of profitability, PATH's ROE is +0.15%, compared to CPAY's ROE of +0.31%. Regarding short-term risk, PATH is less volatile compared to CPAY. This indicates potentially lower risk in terms of short-term price fluctuations for PATH.Check CPAY's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, AKAM has a market cap of 22.5B. Regarding current trading prices, PATH is priced at $10.66, while AKAM trades at $153.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas AKAM's P/E ratio is 51.87. In terms of profitability, PATH's ROE is +0.15%, compared to AKAM's ROE of +0.09%. Regarding short-term risk, PATH is less volatile compared to AKAM. This indicates potentially lower risk in terms of short-term price fluctuations for PATH.Check AKAM's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, AFRM has a market cap of 22.3B. Regarding current trading prices, PATH is priced at $10.66, while AFRM trades at $66.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas AFRM's P/E ratio is 60.41. In terms of profitability, PATH's ROE is +0.15%, compared to AFRM's ROE of +0.11%. Regarding short-term risk, PATH is less volatile compared to AFRM. This indicates potentially lower risk in terms of short-term price fluctuations for PATH.Check AFRM's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, FLT has a market cap of 21.8B. Regarding current trading prices, PATH is priced at $10.66, while FLT trades at $303.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas FLT's P/E ratio is 22.97. In terms of profitability, PATH's ROE is +0.15%, compared to FLT's ROE of +0.31%. Regarding short-term risk, PATH is more volatile compared to FLT. This indicates potentially higher risk in terms of short-term price fluctuations for PATH.Check FLT's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, CYBR has a market cap of 20.6B. Regarding current trading prices, PATH is priced at $10.66, while CYBR trades at $408.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas CYBR's P/E ratio is -139.06. In terms of profitability, PATH's ROE is +0.15%, compared to CYBR's ROE of -0.06%. Regarding short-term risk, PATH is more volatile compared to CYBR. This indicates potentially higher risk in terms of short-term price fluctuations for PATH.Check CYBR's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, FFIV has a market cap of 20.2B. Regarding current trading prices, PATH is priced at $10.66, while FFIV trades at $358.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas FFIV's P/E ratio is 29.42. In terms of profitability, PATH's ROE is +0.15%, compared to FFIV's ROE of +0.20%. Regarding short-term risk, PATH is more volatile compared to FFIV. This indicates potentially higher risk in terms of short-term price fluctuations for PATH.Check FFIV's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, DOCN has a market cap of 17B. Regarding current trading prices, PATH is priced at $10.66, while DOCN trades at $162.72.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas DOCN's P/E ratio is 71.36. In terms of profitability, PATH's ROE is +0.15%, compared to DOCN's ROE of +1.66%. Regarding short-term risk, PATH is less volatile compared to DOCN. This indicates potentially lower risk in terms of short-term price fluctuations for PATH.Check DOCN's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, IOT has a market cap of 16.7B. Regarding current trading prices, PATH is priced at $10.66, while IOT trades at $29.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas IOT's P/E ratio is -1453.00. In terms of profitability, PATH's ROE is +0.15%, compared to IOT's ROE of -0.01%. Regarding short-term risk, PATH is less volatile compared to IOT. This indicates potentially lower risk in terms of short-term price fluctuations for PATH.Check IOT's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, KSPI has a market cap of 16.3B. Regarding current trading prices, PATH is priced at $10.66, while KSPI trades at $85.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas KSPI's P/E ratio is 7.15. In terms of profitability, PATH's ROE is +0.15%, compared to KSPI's ROE of +0.50%. Regarding short-term risk, PATH is less volatile compared to KSPI. This indicates potentially lower risk in terms of short-term price fluctuations for PATH.Check KSPI's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, NLOK has a market cap of 14.3B. Regarding current trading prices, PATH is priced at $10.66, while NLOK trades at $21.66.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas NLOK's P/E ratio is 15.15. In terms of profitability, PATH's ROE is +0.15%, compared to NLOK's ROE of +0.40%. Regarding short-term risk, PATH is less volatile compared to NLOK. This indicates potentially lower risk in terms of short-term price fluctuations for PATH.Check NLOK's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, TOST has a market cap of 14B. Regarding current trading prices, PATH is priced at $10.66, while TOST trades at $24.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas TOST's P/E ratio is 36.10. In terms of profitability, PATH's ROE is +0.15%, compared to TOST's ROE of +0.21%. Regarding short-term risk, PATH is less volatile compared to TOST. This indicates potentially lower risk in terms of short-term price fluctuations for PATH.Check TOST's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, OKTA has a market cap of 13.8B. Regarding current trading prices, PATH is priced at $10.66, while OKTA trades at $81.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas OKTA's P/E ratio is 62.36. In terms of profitability, PATH's ROE is +0.15%, compared to OKTA's ROE of +0.03%. Regarding short-term risk, PATH is less volatile compared to OKTA. This indicates potentially lower risk in terms of short-term price fluctuations for PATH.Check OKTA's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, GEN has a market cap of 13.6B. Regarding current trading prices, PATH is priced at $10.66, while GEN trades at $22.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas GEN's P/E ratio is 14.27. In terms of profitability, PATH's ROE is +0.15%, compared to GEN's ROE of +0.40%. Regarding short-term risk, PATH is less volatile compared to GEN. This indicates potentially lower risk in terms of short-term price fluctuations for PATH.Check GEN's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, PAYP has a market cap of 12.8B. Regarding current trading prices, PATH is priced at $10.66, while PAYP trades at $19.21.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas PAYP's P/E ratio is 16.85. In terms of profitability, PATH's ROE is +0.15%, compared to PAYP's ROE of +0.58%. Regarding short-term risk, PATH is less volatile compared to PAYP. This indicates potentially lower risk in terms of short-term price fluctuations for PATH.Check PAYP's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, RBRK has a market cap of 12.6B. Regarding current trading prices, PATH is priced at $10.66, while RBRK trades at $62.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas RBRK's P/E ratio is -34.93. In terms of profitability, PATH's ROE is +0.15%, compared to RBRK's ROE of +0.64%. Regarding short-term risk, PATH is more volatile compared to RBRK. This indicates potentially higher risk in terms of short-term price fluctuations for PATH.Check RBRK's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, CHKP has a market cap of 12B. Regarding current trading prices, PATH is priced at $10.66, while CHKP trades at $115.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas CHKP's P/E ratio is 11.87. In terms of profitability, PATH's ROE is +0.15%, compared to CHKP's ROE of +0.36%. Regarding short-term risk, PATH is less volatile compared to CHKP. This indicates potentially lower risk in terms of short-term price fluctuations for PATH.Check CHKP's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, NTNX has a market cap of 12B. Regarding current trading prices, PATH is priced at $10.66, while NTNX trades at $45.16.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas NTNX's P/E ratio is 49.11. In terms of profitability, PATH's ROE is +0.15%, compared to NTNX's ROE of -0.37%. Regarding short-term risk, PATH is less volatile compared to NTNX. This indicates potentially lower risk in terms of short-term price fluctuations for PATH.Check NTNX's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, GDDY has a market cap of 11.7B. Regarding current trading prices, PATH is priced at $10.66, while GDDY trades at $88.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas GDDY's P/E ratio is 13.96. In terms of profitability, PATH's ROE is +0.15%, compared to GDDY's ROE of +3.67%. Regarding short-term risk, PATH is less volatile compared to GDDY. This indicates potentially lower risk in terms of short-term price fluctuations for PATH.Check GDDY's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, CFLT has a market cap of 11.1B. Regarding current trading prices, PATH is priced at $10.66, while CFLT trades at $30.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas CFLT's P/E ratio is -36.03. In terms of profitability, PATH's ROE is +0.15%, compared to CFLT's ROE of -0.27%. Regarding short-term risk, PATH is more volatile compared to CFLT. This indicates potentially higher risk in terms of short-term price fluctuations for PATH.Check CFLT's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, ALTR has a market cap of 9.6B. Regarding current trading prices, PATH is priced at $10.66, while ALTR trades at $111.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas ALTR's P/E ratio is 699.06. In terms of profitability, PATH's ROE is +0.15%, compared to ALTR's ROE of +0.02%. Regarding short-term risk, PATH is more volatile compared to ALTR. This indicates potentially higher risk in terms of short-term price fluctuations for PATH.Check ALTR's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, PLAN has a market cap of 9.6B. Regarding current trading prices, PATH is priced at $10.66, while PLAN trades at $63.73.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas PLAN's P/E ratio is -44.82. In terms of profitability, PATH's ROE is +0.15%, compared to PLAN's ROE of -0.78%. Regarding short-term risk, PATH is more volatile compared to PLAN. This indicates potentially higher risk in terms of short-term price fluctuations for PATH.Check PLAN's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, INFA has a market cap of 7.5B. Regarding current trading prices, PATH is priced at $10.66, while INFA trades at $24.79.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas INFA's P/E ratio is 826.33. In terms of profitability, PATH's ROE is +0.15%, compared to INFA's ROE of +0.00%. Regarding short-term risk, PATH is more volatile compared to INFA. This indicates potentially higher risk in terms of short-term price fluctuations for PATH.Check INFA's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, CORZZ has a market cap of 7.3B. Regarding current trading prices, PATH is priced at $10.66, while CORZZ trades at $23.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas CORZZ's P/E ratio is N/A. In terms of profitability, PATH's ROE is +0.15%, compared to CORZZ's ROE of +1.09%. Regarding short-term risk, PATH is less volatile compared to CORZZ. This indicates potentially lower risk in terms of short-term price fluctuations for PATH.Check CORZZ's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, CORZ has a market cap of 7.3B. Regarding current trading prices, PATH is priced at $10.66, while CORZ trades at $22.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas CORZ's P/E ratio is -6.83. In terms of profitability, PATH's ROE is +0.15%, compared to CORZ's ROE of +1.09%. Regarding short-term risk, PATH is less volatile compared to CORZ. This indicates potentially lower risk in terms of short-term price fluctuations for PATH.Check CORZ's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, HCP has a market cap of 7.1B. Regarding current trading prices, PATH is priced at $10.66, while HCP trades at $34.78.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas HCP's P/E ratio is -57.97. In terms of profitability, PATH's ROE is +0.15%, compared to HCP's ROE of -0.16%. Regarding short-term risk, PATH is more volatile compared to HCP. This indicates potentially higher risk in terms of short-term price fluctuations for PATH.Check HCP's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, JCOM has a market cap of 6.8B. Regarding current trading prices, PATH is priced at $10.66, while JCOM trades at $142.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas JCOM's P/E ratio is N/A. In terms of profitability, PATH's ROE is +0.15%, compared to JCOM's ROE of +0.06%. Regarding short-term risk, PATH is less volatile compared to JCOM. This indicates potentially lower risk in terms of short-term price fluctuations for PATH.Check JCOM's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, DBX has a market cap of 6.7B. Regarding current trading prices, PATH is priced at $10.66, while DBX trades at $26.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas DBX's P/E ratio is 14.48. In terms of profitability, PATH's ROE is +0.15%, compared to DBX's ROE of -0.28%. Regarding short-term risk, PATH is less volatile compared to DBX. This indicates potentially lower risk in terms of short-term price fluctuations for PATH.Check DBX's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, DOX has a market cap of 6.7B. Regarding current trading prices, PATH is priced at $10.66, while DOX trades at $62.57.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas DOX's P/E ratio is 12.10. In terms of profitability, PATH's ROE is +0.15%, compared to DOX's ROE of +0.17%. Regarding short-term risk, PATH is more volatile compared to DOX. This indicates potentially higher risk in terms of short-term price fluctuations for PATH.Check DOX's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, SAIL has a market cap of 6.6B. Regarding current trading prices, PATH is priced at $10.66, while SAIL trades at $11.77.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas SAIL's P/E ratio is -21.80. In terms of profitability, PATH's ROE is +0.15%, compared to SAIL's ROE of -0.04%. Regarding short-term risk, PATH is less volatile compared to SAIL. This indicates potentially lower risk in terms of short-term price fluctuations for PATH.Check SAIL's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, BLSH has a market cap of 6.6B. Regarding current trading prices, PATH is priced at $10.66, while BLSH trades at $44.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas BLSH's P/E ratio is -7.35. In terms of profitability, PATH's ROE is +0.15%, compared to BLSH's ROE of -0.26%. Regarding short-term risk, PATH is less volatile compared to BLSH. This indicates potentially lower risk in terms of short-term price fluctuations for PATH.Check BLSH's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, SQSP has a market cap of 6.5B. Regarding current trading prices, PATH is priced at $10.66, while SQSP trades at $46.57.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas SQSP's P/E ratio is -1164.25. In terms of profitability, PATH's ROE is +0.15%, compared to SQSP's ROE of +0.03%. Regarding short-term risk, PATH is more volatile compared to SQSP. This indicates potentially higher risk in terms of short-term price fluctuations for PATH.Check SQSP's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, NEWR has a market cap of 6.2B. Regarding current trading prices, PATH is priced at $10.66, while NEWR trades at $86.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas NEWR's P/E ratio is -41.62. In terms of profitability, PATH's ROE is +0.15%, compared to NEWR's ROE of -0.54%. Regarding short-term risk, PATH is more volatile compared to NEWR. This indicates potentially higher risk in terms of short-term price fluctuations for PATH.Check NEWR's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, CCCS has a market cap of 5.6B. Regarding current trading prices, PATH is priced at $10.66, while CCCS trades at $8.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas CCCS's P/E ratio is -875.00. In terms of profitability, PATH's ROE is +0.15%, compared to CCCS's ROE of +0.02%. Regarding short-term risk, PATH is less volatile compared to CCCS. This indicates potentially lower risk in terms of short-term price fluctuations for PATH.Check CCCS's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, S has a market cap of 5.5B. Regarding current trading prices, PATH is priced at $10.66, while S trades at $16.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas S's P/E ratio is -11.92. In terms of profitability, PATH's ROE is +0.15%, compared to S's ROE of -0.30%. Regarding short-term risk, PATH is less volatile compared to S. This indicates potentially lower risk in terms of short-term price fluctuations for PATH.Check S's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, KLAR has a market cap of 5.4B. Regarding current trading prices, PATH is priced at $10.66, while KLAR trades at $14.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas KLAR's P/E ratio is -18.22. In terms of profitability, PATH's ROE is +0.15%, compared to KLAR's ROE of -0.12%. Regarding short-term risk, PATH is less volatile compared to KLAR. This indicates potentially lower risk in terms of short-term price fluctuations for PATH.Check KLAR's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, CORZW has a market cap of 5.1B. Regarding current trading prices, PATH is priced at $10.66, while CORZW trades at $16.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas CORZW's P/E ratio is N/A. In terms of profitability, PATH's ROE is +0.15%, compared to CORZW's ROE of +1.09%. Regarding short-term risk, PATH is less volatile compared to CORZW. This indicates potentially lower risk in terms of short-term price fluctuations for PATH.Check CORZW's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, RELY has a market cap of 5.1B. Regarding current trading prices, PATH is priced at $10.66, while RELY trades at $24.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas RELY's P/E ratio is 50.58. In terms of profitability, PATH's ROE is +0.15%, compared to RELY's ROE of +0.13%. Regarding short-term risk, PATH is less volatile compared to RELY. This indicates potentially lower risk in terms of short-term price fluctuations for PATH.Check RELY's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, WEX has a market cap of 4.9B. Regarding current trading prices, PATH is priced at $10.66, while WEX trades at $140.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas WEX's P/E ratio is 15.83. In terms of profitability, PATH's ROE is +0.15%, compared to WEX's ROE of +0.27%. Regarding short-term risk, PATH is less volatile compared to WEX. This indicates potentially lower risk in terms of short-term price fluctuations for PATH.Check WEX's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, NVEI has a market cap of 4.8B. Regarding current trading prices, PATH is priced at $10.66, while NVEI trades at $33.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas NVEI's P/E ratio is 212.44. In terms of profitability, PATH's ROE is +0.15%, compared to NVEI's ROE of -0.00%. Regarding short-term risk, PATH is more volatile compared to NVEI. This indicates potentially higher risk in terms of short-term price fluctuations for PATH.Check NVEI's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, KVYO has a market cap of 4.7B. Regarding current trading prices, PATH is priced at $10.66, while KVYO trades at $15.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas KVYO's P/E ratio is -518.00. In terms of profitability, PATH's ROE is +0.15%, compared to KVYO's ROE of -0.01%. Regarding short-term risk, PATH is less volatile compared to KVYO. This indicates potentially lower risk in terms of short-term price fluctuations for PATH.Check KVYO's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, WIX has a market cap of 4.4B. Regarding current trading prices, PATH is priced at $10.66, while WIX trades at $79.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas WIX's P/E ratio is 90.13. In terms of profitability, PATH's ROE is +0.15%, compared to WIX's ROE of -0.22%. Regarding short-term risk, PATH is less volatile compared to WIX. This indicates potentially lower risk in terms of short-term price fluctuations for PATH.Check WIX's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, ACIW has a market cap of 4.3B. Regarding current trading prices, PATH is priced at $10.66, while ACIW trades at $42.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas ACIW's P/E ratio is 21.39. In terms of profitability, PATH's ROE is +0.15%, compared to ACIW's ROE of +0.14%. Regarding short-term risk, PATH is less volatile compared to ACIW. This indicates potentially lower risk in terms of short-term price fluctuations for PATH.Check ACIW's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, ESMT has a market cap of 3.9B. Regarding current trading prices, PATH is priced at $10.66, while ESMT trades at $23.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas ESMT's P/E ratio is 153.67. In terms of profitability, PATH's ROE is +0.15%, compared to ESMT's ROE of +0.03%. Regarding short-term risk, PATH is more volatile compared to ESMT. This indicates potentially higher risk in terms of short-term price fluctuations for PATH.Check ESMT's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, DLO has a market cap of 3.9B. Regarding current trading prices, PATH is priced at $10.66, while DLO trades at $13.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas DLO's P/E ratio is 20.40. In terms of profitability, PATH's ROE is +0.15%, compared to DLO's ROE of +0.38%. Regarding short-term risk, PATH is less volatile compared to DLO. This indicates potentially lower risk in terms of short-term price fluctuations for PATH.Check DLO's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, FOUR has a market cap of 3.8B. Regarding current trading prices, PATH is priced at $10.66, while FOUR trades at $41.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas FOUR's P/E ratio is 47.68. In terms of profitability, PATH's ROE is +0.15%, compared to FOUR's ROE of +0.06%. Regarding short-term risk, PATH is less volatile compared to FOUR. This indicates potentially lower risk in terms of short-term price fluctuations for PATH.Check FOUR's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, BB has a market cap of 3.7B. Regarding current trading prices, PATH is priced at $10.66, while BB trades at $6.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas BB's P/E ratio is 69.06. In terms of profitability, PATH's ROE is +0.15%, compared to BB's ROE of +0.07%. Regarding short-term risk, PATH is less volatile compared to BB. This indicates potentially lower risk in terms of short-term price fluctuations for PATH.Check BB's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, BOX has a market cap of 3.4B. Regarding current trading prices, PATH is priced at $10.66, while BOX trades at $24.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas BOX's P/E ratio is 42.26. In terms of profitability, PATH's ROE is +0.15%, compared to BOX's ROE of +1.16%. Regarding short-term risk, PATH is less volatile compared to BOX. This indicates potentially lower risk in terms of short-term price fluctuations for PATH.Check BOX's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, VRNS has a market cap of 3.3B. Regarding current trading prices, PATH is priced at $10.66, while VRNS trades at $28.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas VRNS's P/E ratio is -24.78. In terms of profitability, PATH's ROE is +0.15%, compared to VRNS's ROE of -0.26%. Regarding short-term risk, PATH is less volatile compared to VRNS. This indicates potentially lower risk in terms of short-term price fluctuations for PATH.Check VRNS's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, CLBT has a market cap of 3.3B. Regarding current trading prices, PATH is priced at $10.66, while CLBT trades at $13.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas CLBT's P/E ratio is 42.10. In terms of profitability, PATH's ROE is +0.15%, compared to CLBT's ROE of +0.18%. Regarding short-term risk, PATH is less volatile compared to CLBT. This indicates potentially lower risk in terms of short-term price fluctuations for PATH.Check CLBT's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, QLYS has a market cap of 3.2B. Regarding current trading prices, PATH is priced at $10.66, while QLYS trades at $91.53.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas QLYS's P/E ratio is 16.43. In terms of profitability, PATH's ROE is +0.15%, compared to QLYS's ROE of +0.37%. Regarding short-term risk, PATH is less volatile compared to QLYS. This indicates potentially lower risk in terms of short-term price fluctuations for PATH.Check QLYS's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, SWI has a market cap of 3.2B. Regarding current trading prices, PATH is priced at $10.66, while SWI trades at $18.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas SWI's P/E ratio is 28.89. In terms of profitability, PATH's ROE is +0.15%, compared to SWI's ROE of +0.08%. Regarding short-term risk, PATH is more volatile compared to SWI. This indicates potentially higher risk in terms of short-term price fluctuations for PATH.Check SWI's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, TDC has a market cap of 3B. Regarding current trading prices, PATH is priced at $10.66, while TDC trades at $32.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas TDC's P/E ratio is 7.39. In terms of profitability, PATH's ROE is +0.15%, compared to TDC's ROE of +1.42%. Regarding short-term risk, PATH is less volatile compared to TDC. This indicates potentially lower risk in terms of short-term price fluctuations for PATH.Check TDC's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, EVOP has a market cap of 3B. Regarding current trading prices, PATH is priced at $10.66, while EVOP trades at $33.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas EVOP's P/E ratio is -309.00. In terms of profitability, PATH's ROE is +0.15%, compared to EVOP's ROE of -0.03%. Regarding short-term risk, PATH is more volatile compared to EVOP. This indicates potentially higher risk in terms of short-term price fluctuations for PATH.Check EVOP's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, NTCT has a market cap of 2.9B. Regarding current trading prices, PATH is priced at $10.66, while NTCT trades at $40.67.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas NTCT's P/E ratio is 31.28. In terms of profitability, PATH's ROE is +0.15%, compared to NTCT's ROE of +0.06%. Regarding short-term risk, PATH is less volatile compared to NTCT. This indicates potentially lower risk in terms of short-term price fluctuations for PATH.Check NTCT's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, PAGS has a market cap of 2.9B. Regarding current trading prices, PATH is priced at $10.66, while PAGS trades at $9.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas PAGS's P/E ratio is 6.77. In terms of profitability, PATH's ROE is +0.15%, compared to PAGS's ROE of +0.14%. Regarding short-term risk, PATH is less volatile compared to PAGS. This indicates potentially lower risk in terms of short-term price fluctuations for PATH.Check PAGS's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, CCC has a market cap of 2.9B. Regarding current trading prices, PATH is priced at $10.66, while CCC trades at $4.88.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas CCC's P/E ratio is 81.33. In terms of profitability, PATH's ROE is +0.15%, compared to CCC's ROE of +0.02%. Regarding short-term risk, PATH is less volatile compared to CCC. This indicates potentially lower risk in terms of short-term price fluctuations for PATH.Check CCC's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, STNE has a market cap of 2.8B. Regarding current trading prices, PATH is priced at $10.66, while STNE trades at $10.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas STNE's P/E ratio is 5.95. In terms of profitability, PATH's ROE is +0.15%, compared to STNE's ROE of +0.20%. Regarding short-term risk, PATH is less volatile compared to STNE. This indicates potentially lower risk in terms of short-term price fluctuations for PATH.Check STNE's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, EEFT has a market cap of 2.6B. Regarding current trading prices, PATH is priced at $10.66, while EEFT trades at $69.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas EEFT's P/E ratio is 10.21. In terms of profitability, PATH's ROE is +0.15%, compared to EEFT's ROE of +0.24%. Regarding short-term risk, PATH is less volatile compared to EEFT. This indicates potentially lower risk in terms of short-term price fluctuations for PATH.Check EEFT's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, WRD has a market cap of 2.5B. Regarding current trading prices, PATH is priced at $10.66, while WRD trades at $7.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas WRD's P/E ratio is -9.82. In terms of profitability, PATH's ROE is +0.15%, compared to WRD's ROE of -0.24%. Regarding short-term risk, PATH is less volatile compared to WRD. This indicates potentially lower risk in terms of short-term price fluctuations for PATH.Check WRD's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, TENB has a market cap of 2.3B. Regarding current trading prices, PATH is priced at $10.66, while TENB trades at $21.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas TENB's P/E ratio is -213.10. In terms of profitability, PATH's ROE is +0.15%, compared to TENB's ROE of -0.04%. Regarding short-term risk, PATH is less volatile compared to TENB. This indicates potentially lower risk in terms of short-term price fluctuations for PATH.Check TENB's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, CSGS has a market cap of 2.3B. Regarding current trading prices, PATH is priced at $10.66, while CSGS trades at $80.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas CSGS's P/E ratio is 35.87. In terms of profitability, PATH's ROE is +0.15%, compared to CSGS's ROE of +0.22%. Regarding short-term risk, PATH is more volatile compared to CSGS. This indicates potentially higher risk in terms of short-term price fluctuations for PATH.Check CSGS's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, AVPT has a market cap of 2.2B. Regarding current trading prices, PATH is priced at $10.66, while AVPT trades at $10.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas AVPT's P/E ratio is 52.35. In terms of profitability, PATH's ROE is +0.15%, compared to AVPT's ROE of +0.10%. Regarding short-term risk, PATH is less volatile compared to AVPT. This indicates potentially lower risk in terms of short-term price fluctuations for PATH.Check AVPT's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, AVDX has a market cap of 2.1B. Regarding current trading prices, PATH is priced at $10.66, while AVDX trades at $10.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas AVDX's P/E ratio is -250.00. In terms of profitability, PATH's ROE is +0.15%, compared to AVDX's ROE of -0.02%. Regarding short-term risk, PATH is more volatile compared to AVDX. This indicates potentially higher risk in terms of short-term price fluctuations for PATH.Check AVDX's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, GETVV has a market cap of 2.1B. Regarding current trading prices, PATH is priced at $10.66, while GETVV trades at $2.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas GETVV's P/E ratio is N/A. In terms of profitability, PATH's ROE is +0.15%, compared to GETVV's ROE of N/A. Regarding short-term risk, PATH is less volatile compared to GETVV. This indicates potentially lower risk in terms of short-term price fluctuations for PATH.Check GETVV's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, ATEN has a market cap of 2B. Regarding current trading prices, PATH is priced at $10.66, while ATEN trades at $28.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas ATEN's P/E ratio is 45.92. In terms of profitability, PATH's ROE is +0.15%, compared to ATEN's ROE of +0.21%. Regarding short-term risk, PATH is more volatile compared to ATEN. This indicates potentially higher risk in terms of short-term price fluctuations for PATH.Check ATEN's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, FORG has a market cap of 2B. Regarding current trading prices, PATH is priced at $10.66, while FORG trades at $23.21.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas FORG's P/E ratio is -22.53. In terms of profitability, PATH's ROE is +0.15%, compared to FORG's ROE of -0.20%. Regarding short-term risk, PATH is less volatile compared to FORG. This indicates potentially lower risk in terms of short-term price fluctuations for PATH.Check FORG's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, EVCM has a market cap of 1.9B. Regarding current trading prices, PATH is priced at $10.66, while EVCM trades at $11.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas EVCM's P/E ratio is 84.62. In terms of profitability, PATH's ROE is +0.15%, compared to EVCM's ROE of +0.04%. Regarding short-term risk, PATH is less volatile compared to EVCM. This indicates potentially lower risk in terms of short-term price fluctuations for PATH.Check EVCM's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, SPSC has a market cap of 1.9B. Regarding current trading prices, PATH is priced at $10.66, while SPSC trades at $52.78.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas SPSC's P/E ratio is 21.90. In terms of profitability, PATH's ROE is +0.15%, compared to SPSC's ROE of +0.09%. Regarding short-term risk, PATH is less volatile compared to SPSC. This indicates potentially lower risk in terms of short-term price fluctuations for PATH.Check SPSC's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, GSKY has a market cap of 1.9B. Regarding current trading prices, PATH is priced at $10.66, while GSKY trades at $10.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas GSKY's P/E ratio is 18.61. In terms of profitability, PATH's ROE is +0.15%, compared to GSKY's ROE of +5.47%. Regarding short-term risk, PATH is more volatile compared to GSKY. This indicates potentially higher risk in terms of short-term price fluctuations for PATH.Check GSKY's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, RAMP has a market cap of 1.9B. Regarding current trading prices, PATH is priced at $10.66, while RAMP trades at $29.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas RAMP's P/E ratio is 28.21. In terms of profitability, PATH's ROE is +0.15%, compared to RAMP's ROE of +0.07%. Regarding short-term risk, PATH is less volatile compared to RAMP. This indicates potentially lower risk in terms of short-term price fluctuations for PATH.Check RAMP's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, GET has a market cap of 1.8B. Regarding current trading prices, PATH is priced at $10.66, while GET trades at $1.88.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas GET's P/E ratio is 31.33. In terms of profitability, PATH's ROE is +0.15%, compared to GET's ROE of N/A. Regarding short-term risk, PATH is less volatile compared to GET. This indicates potentially lower risk in terms of short-term price fluctuations for PATH.Check GET's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, MQ has a market cap of 1.7B. Regarding current trading prices, PATH is priced at $10.66, while MQ trades at $4.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas MQ's P/E ratio is 405.50. In terms of profitability, PATH's ROE is +0.15%, compared to MQ's ROE of +0.00%. Regarding short-term risk, PATH is less volatile compared to MQ. This indicates potentially lower risk in terms of short-term price fluctuations for PATH.Check MQ's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, PAYO has a market cap of 1.7B. Regarding current trading prices, PATH is priced at $10.66, while PAYO trades at $5.11.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas PAYO's P/E ratio is 25.55. In terms of profitability, PATH's ROE is +0.15%, compared to PAYO's ROE of +0.10%. Regarding short-term risk, PATH is less volatile compared to PAYO. This indicates potentially lower risk in terms of short-term price fluctuations for PATH.Check PAYO's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, STER has a market cap of 1.6B. Regarding current trading prices, PATH is priced at $10.66, while STER trades at $16.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas STER's P/E ratio is -98.47. In terms of profitability, PATH's ROE is +0.15%, compared to STER's ROE of -0.00%. Regarding short-term risk, PATH is more volatile compared to STER. This indicates potentially higher risk in terms of short-term price fluctuations for PATH.Check STER's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, FIVN has a market cap of 1.6B. Regarding current trading prices, PATH is priced at $10.66, while FIVN trades at $21.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas FIVN's P/E ratio is 32.94. In terms of profitability, PATH's ROE is +0.15%, compared to FIVN's ROE of +0.07%. Regarding short-term risk, PATH is less volatile compared to FIVN. This indicates potentially lower risk in terms of short-term price fluctuations for PATH.Check FIVN's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, BAND has a market cap of 1.6B. Regarding current trading prices, PATH is priced at $10.66, while BAND trades at $49.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas BAND's P/E ratio is -131.45. In terms of profitability, PATH's ROE is +0.15%, compared to BAND's ROE of -0.01%. Regarding short-term risk, PATH is less volatile compared to BAND. This indicates potentially lower risk in terms of short-term price fluctuations for PATH.Check BAND's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, ZUO has a market cap of 1.5B. Regarding current trading prices, PATH is priced at $10.66, while ZUO trades at $10.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas ZUO's P/E ratio is -19.65. In terms of profitability, PATH's ROE is +0.15%, compared to ZUO's ROE of -0.44%. Regarding short-term risk, PATH is more volatile compared to ZUO. This indicates potentially higher risk in terms of short-term price fluctuations for PATH.Check ZUO's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, PICS has a market cap of 1.5B. Regarding current trading prices, PATH is priced at $10.66, while PICS trades at $11.86.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas PICS's P/E ratio is 6.98. In terms of profitability, PATH's ROE is +0.15%, compared to PICS's ROE of +0.16%. Regarding short-term risk, PATH is less volatile compared to PICS. This indicates potentially lower risk in terms of short-term price fluctuations for PATH.Check PICS's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, APPN has a market cap of 1.5B. Regarding current trading prices, PATH is priced at $10.66, while APPN trades at $20.53.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas APPN's P/E ratio is 1026.50. In terms of profitability, PATH's ROE is +0.15%, compared to APPN's ROE of -0.02%. Regarding short-term risk, PATH is less volatile compared to APPN. This indicates potentially lower risk in terms of short-term price fluctuations for PATH.Check APPN's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, TUYA has a market cap of 1.5B. Regarding current trading prices, PATH is priced at $10.66, while TUYA trades at $2.46.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas TUYA's P/E ratio is 27.50. In terms of profitability, PATH's ROE is +0.15%, compared to TUYA's ROE of +0.06%. Regarding short-term risk, PATH is less volatile compared to TUYA. This indicates potentially lower risk in terms of short-term price fluctuations for PATH.Check TUYA's competition here

PATH plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PATH stands at 5.7B. In comparison, SUMO has a market cap of 1.5B. Regarding current trading prices, PATH is priced at $10.66, while SUMO trades at $12.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PATH currently has a P/E ratio of 20.49, whereas SUMO's P/E ratio is -11.36. In terms of profitability, PATH's ROE is +0.15%, compared to SUMO's ROE of -0.31%. Regarding short-term risk, PATH is more volatile compared to SUMO. This indicates potentially higher risk in terms of short-term price fluctuations for PATH.Check SUMO's competition here